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receptors undergo change in diffusion
coefficient. This was demonstrated by
labeling cells with IgEs with different
specificities (dansyl and DNP). Antigen-
containing DNP could not cause a change
in diffusion of IgE specific for Dansyl. The
second observation they made was that
cells treated with inhibitors of Src family
kinases showed no change in the as-
sembly of signaling complexes or their
diffusion characteristics. This result is
very similar to what has been observed
for TCR microclusters; however, the
same may not be true for BCR signaling
(Fleire et al., 2006; Tolar et al., 2005).
The data presented here have impor-
tant implications in understanding sig-
naling via ITAM-containing receptors in
the immune system. TCR and BCR under-
go microcluster formation upon encoun-
tering antigen and is also the site where
antigen accumulates. This paper raises
the possibility that transient interactions
between antigen receptors and their
ligands outside of microclusters that do
not cause receptor clustering or immobili-
zation may still generate signals or that
microcluster formation succeeds such
transient interactions. In the future, prog-
ress in imaging technology and computer
modeling of microscopy data is likely to
illuminate this world of signaling.
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Gut lamina propria dendritic cell (DC) subsets have specialized functions. In this issue of Immunity, Varol et al.
(2009) and Bogunovic et al. (2009) describe the different blood precursors for CD103+ and CD103 DC
subsets.How the intestine can tolerate trillions of
intestinal bacteria, initiate tolerance to-
ward food antigens, and fight infections
is the subject of an intense area of re-
search. Recent advances have high-
lighted a fundamental role of dendritic
cells (DCs) in these functions. In the
mouse lamina propria (LP), DCs are char-
acterized by the high expression of
CD11c and can be distinguished based
on the expression of the integrin CD103,
which recognizes E-cadherin. CD103+
DCs can drive the differentiation of T regu-
latory (Treg) cells, the effectors of toler-
ance, via a mechanism that is mediated
by retinoic acid (RA) and TGF-b (Sun
et al., 2007). In contrast, CD103 DCs
can be subdivided into two subsets. One
subset expresses CX3CR1 and drives
the development of T helper 17 (Th17)
cells (Atarashi et al., 2008). The other454 Immunity 31, September 18, 2009 ª200subset expresses the Toll-like receptor 5
(TLR5) and drives the differentiation of
both Th17 cells and IgA class-switched
B cells (Uematsu et al., 2008). However,
it was not clear whether these DCs re-
presented different activation states of
the same subset (expressing or not the
CD103) or whether they represented two
different subsets arising from distinct
blood precursors.
In this issue of Immunity, two indepen-
dent reports by Varol et al. (2009) and
Bogunovic et al. (2009) describe that the
CD103+ and CD103 DC subsets are fur-
ther distinguishable based on the expres-
sion of CD11b and CX3CR1 and derive
from different bone marrow precursors.
By using very elegant model systems
based on conditional ablation of DCs
and engraftment with defined DC precur-
sors, the two groups demonstrate that a9 Elsevier Inc.common macrophage and DC precursor
(MDP) can give rise to both CD103+ and
CD103 DCs, whereas pre-DCs or mono-
cytes can differentiate only into CD103+ or
CD103 DCs, respectively (Figure 1).
These studies also describe the different
requirements of growth factors for the
differentiation of the two major DC sub-
sets. Both reports show a common re-
quirement of Flt3L for the differentiation
of CD11b+CD103+ and CD11bCD103+
DCs whereas Varol et al. (2009) show
that GM-CSF seems to be more involved
in the differentiation of CD11b+ (mostly
CD103) DCs. In contrast, Bogunovic
et al. (2009) find that GM-CSFR expres-
sion is dispensable for CD103 DC differ-
entiation, whereas it is required for the
differentiation of CD11b+CD103+ and
CD11bCD103+ DCs. Bogunovic et al.
(2009) also demonstrate a requirement
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PreviewsFigure 1. Origin and Function of Lamina Propria DCs
Under steady-state conditions, blood DC precursors give origin to lamina propria (LP) DCs. Ly6Chi monocytes differentiate into CD103CX3CR1+ DCs presum-
ably under the influence of ATP-producing or flagellated bacteria and induce Th17 cell differentiation. In contrast, pre-DCs give rise to CD103+ DCs in the pres-
ence of RA and TGF-b released by epithelial cells. CD103+ DCs are tolerogenic and induce Treg cell differentiation after their migration to the mesenteric lymph
node. During infection, even though both CD103+CX3CR1
 andCD103CX3CR1
+DCs have taken upSalmonella, CD103+DCs are the first tomigrate to theMLN.
It is not known the function of these DCs, or whether they still induce Treg cells. When CD103+ DCs are lacking inmice deleted for DCs and reconstituted only with
Ly6Chi monocytes (blue box), mice are more susceptible to DSS colitis. This may be due to the capacity of CX3CR1
+ DCs to polarize Th17 cells. Alternatively, and
not mutually exclusive, inflammatory monocytes may drive the differentiation of Th1-cell-inducing DCs.of M-CSFR for the differentiation of the
CD103 population. This apparent dis-
crepancy may be due to the different
way used by the two groups to phenotyp-
ically separate the two cell types. In both
cases, the cells were separated based
on the high expression of CD11c expres-
sion, but whereas Varol et al. (2009) report
that they separated the cells based on the
expression of CD11b and CX3CR1, Bogu-
novic et al. (2009) report that they sepa-
rated the DCs based on the expression
of MHC class II and CD11b. In addition,
as shown by Bogunovic et al. (2009),
different compartments of either the small
or large intestine (i.e., the intestinal epithe-
lial cell fraction, the LP, the serosa, or the
muscolaris) yielded different DC popula-
tions, including a contaminating lymphoid
population characterized by the expres-
sion of CD103 and the absence of
CD11b. Hence, it is likely that the same
progenitor may require different growth
factors or combination of growth factors
for their differentiation depending on the
compartment that is analyzed.
The different origin of the DC popula-
tions reflects differences in DC function.When the mesenteric lymph node (MLN)
is analyzed, it is clear that again that the
DC populations can be distinguished
based on CD103 expression; however,
whereas the CD103+ population ex-
presses CCR7 and seems to be derived
from a migratory LP CD103+ DC popula-
tion, the CD103 DC population seems
to be a resident nonmigratory cell type.
Indeed, only 20% of MLN CD103 DCs
express high CX3CR1, suggesting a
different origin than LP CD103 DCs that
uniformly express CX3CR1. This is an
intriguing observation because it indi-
cates that under steady-state condition,
only CD103+ DCs can migrate into the
MLN. This population is required for the
differentiation of Treg cells (Coombes
et al., 2007), and therefore it could be
involved in tolerance induction to food
antigens. What was unexpected is that
CD103+CX3CR1
 DCs are also required
for the initial transport of Salmonella
from the intestine to the MLN (Bogunovic
et al., 2009). Indeed, it has been shown
that DCs can extend protrusions across
the epithelial barrier (Rescigno et al.,
2001), andCX3CR1 expression is requiredImmunity 31, Sfor DC extensions (Niess et al., 2005).
Hence it would be more logical to think
that CD103CX3CR1
+ DCs are the first
to migrate to MLNs and to carry ingested
microbes. In the model used by Bogu-
novic et al. (2009), mice are treated
with streptomycin and this facilitates
Salmonella entrance across epithelial
cells. Thus, it is likely that CD103+ DCs
acquire Salmonella after their indepen-
dent crossing across the epithelial barrier.
However, it cannot be excluded that
CD103+ DCs may also extend their pro-
trusions across the epithelial barrier
because we have observed that DC
extensions in CX3CR1-GFP and MHC
II-GFP mice are only partly overlapping
(unpublished observations), suggesting
that two populations of DCs may
extend protrusions in the lumen. Alterna-




 DCs but this has not
been demonstrated. Regardless, it
appears that CD103+ DCsmay be the first
cells migrating to the draining MLN both
under steady-state and under infection
conditions. It is not clear what is theeptember 18, 2009 ª2009 Elsevier Inc. 455
Immunity
Previewsfunction of these migrating CD103+ DCs
carrying the Salmonella into the MLN
given their propensity to drive Treg cell
development (Coombes et al., 2007).
These cells could be exploited by Salmo-
nella for its own spreading in the absence
of productive immunity, but this remains
to be established.
Varol et al. (2009) have instead fo-
cused on the role of monocyte-derived
CD103CX3CR1
+ DCs. By conditionally
ablating mice of DCs and reconstituting
them with monocytes that give rise only
to CD103CX3CR1
+ DCs, they have
shown that these DCs are sufficient to
restore the internalization of noninvasive
Salmonella and to present orally adminis-
tered antigens. However, it remains to be
established what is the outcome of this
presentation, in terms of T cell activation
and polarization. Varol et al. (2009) also
show that when mice display only
CD103CX3CR1+ DCs, they are more
susceptible to DSS-induced colitis. This
may be the result of at least two non-
mutually exclusive possible scenarios.
The first is that CD103+ DCs are required
to maintain tolerance in the gut because
they drive the development of Treg cells
that may be involved in preserving tissue
integrity or limiting inflammatory damage.
In the absence of CD103+ DCs, there may
be a decrease in Treg cell differentiation
and a concomitant increase in the devel-
opment of colitogenic Th17 cells as indi-
cated by the fact that CD103CX3CR1
+
DCs have been shown to drive Th17 cell
development in the presence of bac-
teria-derived ATP (Atarashi et al., 2008).
Hence, the balance between CD103+
and CD103 DCs is required to preserve
gut homeostasis. The second possibility
may be the capacity of the local microen-
vironment to control DC function and to
inhibit the development of inflammatory
Th1 cell-type of responses (Iliev et al.,
2009). Indeed, resident LP DCs are
unable to produce IL-12 and to drive
Th1 cell-type of responses because they
either lack TLR expression (except for
TLR5) or they are unresponsive to TLR
stimulation (Monteleone et al., 2008). It
is possible that CD103CX3CR1+ DCs
arising from the transferred monocytes
may not have time to be conditioned by
the local microenvironment in the
absence of CD103+ DCs and become
‘‘inflammatory’’ leading to Th1 cell differ-456 Immunity 31, September 18, 2009 ª200entiation. Additional studies are required
to address this issue.
It remains to be understood whether
monocytes are recruited at all during
steady-state. Bogunovic et al. (2009)
show that in the absence of DC ablation,
monocytes are unable to repopulate the
LP and to give rise to CD103 DCs. This
could be due to the low turn-over of
CD103 DCs in the LP because in mice
connectedbyparabiosis, only theCD103+
population is replenished by parabiont-
derived cells, whereas the CD103 popu-
lation is not. Alternatively, it could be due
to the proliferation of either themonocytes
or the differentiated CD103 DCs directly
in situ (Jaensson et al., 2008). In contrast,
DC ablation could lead to the elimination
of both cell types and to the need to recon-
stitute the DC pools by recruitment of
blood precursors.
What is the function of CX3CR1
+ DCs?
One possibility would be that they are
responsible to confer an initial protection
toward commensals and pathogenic
microorganisms via the induction (or re-
stimulation) of Th17 cells. Alternatively,
these cells may migrate at later time
points after infection and may be respon-
sible for the initiation of Th17 cell differen-
tiation in the draining lymph nodes.
Another intriguing possibility is that
CD103CX3CR1+ DCs offer only an initial
defense whereas the cells responsible for
the initiation of a protective immune re-
sponse toward Salmonella are inflamma-
tory monocytes that are recruited after
infection. These recruited monocytes
may differentiate into an additional inflam-
matory type of DCs that can initiate Th1
cell immune responses to Salmonella.
Another important question that arises
from the present studies is whether the
progenitor cells are intrinsically com-
mitted to become CD103+ or CD103
cells and to acquire their mucosal spe-
cialized functions or whether these
characteristics are extrinsically conferred
by the local microenvironment. It has
been shown that it is possible to ‘‘condi-
tion’’ bone-marrow-derived DCs into the
CD103+ phenotype of mucosal DCs. In
particular, the direct interaction with
epithelial cells drives the upregulation of
CD103 whereas soluble factors released
by epithelial cells, including RA and
TGF-b, mediate the acquisition of tolero-
genic properties (Figure 1; Iliev et al.,9 Elsevier Inc.2009). In this context, Bogunovic et al.
(2009) have shown that CD103+ DCs are
often associated with epithelial cells. In
contrast, it is possible that the phenotype
of CX3CR1
+ DCs is conferred directly by
the luminal bacteria as indicated by the
fact that bacteria-derived ATP is required
to drive Th17-cell-inducing DCs (Atarashi
et al., 2008). Hence different environ-
mental conditions may confer the proper-
ties to CD103+ and CD103 DCs.
In conclusion, at least two different
blood precursors differentiate into distinct
LP DC subsets in response to specific
growth factors. The challenge is to identify
themolecular pathways of this differentia-
tion and where it occurs.
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